Zaroxolyn · DIN 00888400 · 2.5 mg · tablet
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Zaroxolyn · DIN 00888400
Manufacturer: Sanofi Aventis Pharma; listing date 1996-10-01
Health Canada: Marketed since 2008-01-21 · brand ZAROXOLYN · ATC C03BA08 METOLAZONE · form Tablet · route Oral · ingredients METOLAZONE 2.5 MG · company Sanofi-aventis canada inc · schedule Prescription
Zaroxolyn: Formulary list price $0.23 per unit (the source does not state the unit; exact figure $0.2294). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00888400)
Source record
DIN 00888400: Zaroxolyn
Raw flags: chronicUseMed=Y, sec3=Y
Item: 402800035; group id 565; item number 1509; lccId None; manufacturer id SAV
Source form: Tab; strength: 2.5mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2294; ministry $0.2294
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00888400
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13126
Shortage status: not checked (no credentials)